PUBLISHER: 360iResearch | PRODUCT CODE: 1589605

PUBLISHER: 360iResearch | PRODUCT CODE: 1589605

Drug Testing Market by Drug Testing Product (Assay Kits, Consumables, Drug Screening Services), Sample Type (Breath Samples, Hair Samples, Oral Fluid Samples), End-User - Global Forecast 2025-2030

PUBLISHED: October 31, 2024

PAGES: 182 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The Drug Testing Market was valued at USD 22.25 billion in 2023, expected to reach USD 24.94 billion in 2024, and is projected to grow at a CAGR of 12.18%, to USD 49.76 billion by 2030.

The scope of drug testing lies in its crucial role in promoting workplace safety, compliance in competitive sports, and rehabilitation. Defined as the analysis of biological samples to identify the presence of specific substances, drug testing is necessary for maintaining occupational safety standards, legal compliance, and personal responsibility. Its applications are vast, spanning sectors like healthcare, law enforcement, sports, and corporate, with end-use encompassing diverse industries from transportation to athletics. The drug testing market's growth is primarily fueled by increased substance abuse, stringent regulatory requirements, and greater employer demand to ensure safer environments, enhancing productivity. Key growth opportunities are emerging with the development of advanced technology like rapid and non-invasive testing methods, reflecting consumer preferences towards efficiency and privacy. Market players should invest in research targeting the integration of AI and machine learning for quicker, more accurate test results. However, challenges include ethical concerns regarding privacy, the high cost of advanced testing kits, and legal complexities across different regions. The potential for error in test results and the limited scope of specific tests further hinder market growth. In terms of innovation, the market can benefit from exploring blockchain for secure data handling and biomarker discovery for enhanced testing specificity. Furthermore, the introduction of portable and digital testing devices could revolutionize personal and organizational compliance management. The nature of the drug testing market is competitive, with continuous advancements and regulatory changes maintaining dynamic market conditions. Companies need to tailor their strategies to the evolving legislative landscape and technological advancements to capitalize on existing opportunities and bridge existing gaps effectively. Engaging in strategic partnerships and expanding service offerings could help navigate market complexities and foster sustainable growth in this essential industry.

KEY MARKET STATISTICS
Base Year [2023]	USD 22.25 billion
Estimated Year [2024]	USD 24.94 billion
Forecast Year [2030]	USD 49.76 billion
CAGR (%)	12.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Testing Market

The Drug Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Growing drug & alcohol consumption
- Stringent government regulations for drug & alcohol testing
- Surge in regulatory approvals and product & service development
Market Restraints
- Restriction on the drug testing as it is violation of privacy rights in some countries
Market Opportunities
- Development of advanced drug testing solutions
- Intelligent fingerprint drug testing system
Market Challenges
- Technical problem in interpreting screening tests and social issue

Porter's Five Forces: A Strategic Tool for Navigating the Drug Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Testing Market

A detailed market share analysis in the Drug Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Testing Market

A strategic analysis of the Drug Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Legacy Medical Services, LLC., Omega Laboratories, Inc., Quest Diagnostics, Quidel Corporation, Sciteck Clinical Laboratories, Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Drug Testing Product, market is studied across Assay Kits, Consumables, Drug Screening Services, and Products. The Products is further studied across Analytical Instruments, Calibrators & Controls, Rapid Testing Devices, and Sample Collection Tubes. The Analytical Instruments is further studied across Breathalyzers, Chromatography Instruments, and Immunoassay Analyzers. The Rapid Testing Devices is further studied across Oral Fluid Testing Devices and Urine Testing Devices.
Based on Sample Type, market is studied across Breath Samples, Hair Samples, Oral Fluid Samples, and Urine Samples.
Based on End-User, market is studied across Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Individual Users, Pain Management Centers, Universities, and Workplace.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-B973EDD5EB02

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing drug & alcohol consumption
  - 5.1.1.2. Stringent government regulations for drug & alcohol testing
  - 5.1.1.3. Surge in regulatory approvals and product & service development
- 5.1.2. Restraints
  - 5.1.2.1. Restriction on the drug testing as it is violation of privacy rights in some countries
- 5.1.3. Opportunities
  - 5.1.3.1. Development of advanced drug testing solutions
  - 5.1.3.2. Intelligent fingerprint drug testing system
- 5.1.4. Challenges
  - 5.1.4.1. Technical problem in interpreting screening tests and social issue
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Drug Testing Market, by Drug Testing Product

6.1. Introduction
6.2. Assay Kits
6.3. Consumables
6.4. Drug Screening Services
6.5. Products
- 6.5.1. Analytical Instruments
  - 6.5.1.1. Breathalyzers
  - 6.5.1.2. Chromatography Instruments
  - 6.5.1.3. Immunoassay Analyzers
- 6.5.2. Calibrators & Controls
- 6.5.3. Rapid Testing Devices
  - 6.5.3.1. Oral Fluid Testing Devices
  - 6.5.3.2. Urine Testing Devices
- 6.5.4. Sample Collection Tubes

7. Drug Testing Market, by Sample Type

7.1. Introduction
7.2. Breath Samples
7.3. Hair Samples
7.4. Oral Fluid Samples
7.5. Urine Samples

8. Drug Testing Market, by End-User

8.1. Introduction
8.2. Criminal Justice Systems & Law Enforcement Agencies
8.3. Drug Testing Laboratories
8.4. Drug Treatment Centers
8.5. Hospitals
8.6. Individual Users
8.7. Pain Management Centers
8.8. Universities
8.9. Workplace

9. Americas Drug Testing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Drug Testing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Drug Testing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abbott Laboratories
2. Agilent Technologies, Inc.
3. Alfa Scientific Designs, Inc.
4. Bio-Rad Laboratories, Inc.
5. Clinical Reference Laboratory, Inc.
6. Cordant Health Solutions
7. Dragerwerk AG & Co. KGaA
8. F. Hoffmann-La Roche AG
9. Legacy Medical Services, LLC.
10. Omega Laboratories, Inc.
11. Quest Diagnostics
12. Quidel Corporation
13. Sciteck Clinical Laboratories
14. Siemens Healthineers AG
15. Thermo Fisher Scientific Inc.

Product Code: MRR-B973EDD5EB02

LIST OF FIGURES

FIGURE 1. DRUG TESTING MARKET RESEARCH PROCESS
FIGURE 2. DRUG TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. DRUG TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DRUG TESTING MARKET DYNAMICS
TABLE 7. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG TESTING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG TESTING MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG TESTING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG TESTING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG TESTING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG TESTING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG TESTING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG TESTING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG TESTING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CANADA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 59. CANADA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 60. CANADA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 61. CANADA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. MEXICO DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. MEXICO DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 67. MEXICO DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. CHINA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. CHINA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 91. CHINA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 92. CHINA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 93. CHINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 94. CHINA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. INDIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. INDIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 97. INDIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 98. INDIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 99. INDIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 100. INDIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. JAPAN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. JAPAN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 109. JAPAN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 110. JAPAN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 111. JAPAN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 112. JAPAN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 130. SINGAPORE DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 136. SOUTH KOREA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 142. TAIWAN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. THAILAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. THAILAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 145. THAILAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 146. THAILAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 147. THAILAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 148. THAILAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 154. VIETNAM DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 162. DENMARK DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. DENMARK DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 164. DENMARK DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. DENMARK DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 166. DENMARK DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 167. DENMARK DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. EGYPT DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. EGYPT DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 170. EGYPT DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 171. EGYPT DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 172. EGYPT DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 173. EGYPT DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. FINLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. FINLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 177. FINLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 178. FINLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 179. FINLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. FRANCE DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. FRANCE DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 182. FRANCE DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 183. FRANCE DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 184. FRANCE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 185. FRANCE DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. GERMANY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. GERMANY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 188. GERMANY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 190. GERMANY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 191. GERMANY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 197. ISRAEL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. ITALY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. ITALY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 200. ITALY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 201. ITALY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 202. ITALY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 203. ITALY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. NORWAY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. NORWAY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 218. NORWAY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 219. NORWAY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 220. NORWAY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 221. NORWAY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. POLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. POLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 224. POLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 225. POLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 226. POLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 227. POLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. QATAR DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. QATAR DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 230. QATAR DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. QATAR DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 232. QATAR DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 233. QATAR DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. SPAIN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. SPAIN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 254. SPAIN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 255. SPAIN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 256. SPAIN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 257. SPAIN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. TURKEY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. TURKEY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 272. TURKEY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 273. TURKEY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 274. TURKEY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 275. TURKEY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 289. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ